36 related articles for article (PubMed ID: 35139397)
1. Expression of autocrine motility factor receptor (AMFR) in human breast and lung invasive micropapillary carcinomas.
Xu J; Ma H; Wang Q; Zhang H
Int J Exp Pathol; 2023 Feb; 104(1):43-51. PubMed ID: 36576071
[TBL] [Abstract][Full Text] [Related]
2. Integrative Proteomic and Phosphoproteomic Analyses of Granulosa Cells During Follicular Atresia in Porcine.
Yang F; Liu Q; Chen Y; Ye H; Wang H; Zeng S
Front Cell Dev Biol; 2020; 8():624985. PubMed ID: 33520998
[TBL] [Abstract][Full Text] [Related]
3. Proteome-based molecular subtyping and therapeutic target prediction in gastric cancer.
Hu C; Song J; Kwok T; Nguyen EV; Shen X; Daly RJ
Mol Oncol; 2024 Apr; ():. PubMed ID: 38627210
[TBL] [Abstract][Full Text] [Related]
4. Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts.
Chen Y; Roselli S; Panicker N; Brzozowski JS; Skerrett-Byrne DA; Murray HC; Verrills NM
Proteomics; 2024 Apr; 24(7):e2300267. PubMed ID: 37849217
[TBL] [Abstract][Full Text] [Related]
5. Combined Proteomic and Phosphoproteomic Characterization of the Molecular Regulators and Functional Modules During Pancreatic Progenitor Cell Development.
He Q; Xu S; He F; Wu Z; Wu F; Zhou R; Zhou B; Li F; Yang X
J Proteome Res; 2024 Jan; 23(1):40-51. PubMed ID: 37993262
[TBL] [Abstract][Full Text] [Related]
6. Proteomic and phosphoproteomic characterization of cardiovascular tissues after long term exposure to simulated space radiation.
Kidane YH; Lee FH; Smith MF; Wang C; Mirza JB; Sharma S; Lobo AA; Dewan KC; Chen J; Diaz TE; Pla MM; Foster MW; Bowles DE
Front Physiol; 2024; 15():1248276. PubMed ID: 38699144
[No Abstract] [Full Text] [Related]
7. Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome.
Guo T; Lee SS; Ng WH; Zhu Y; Gan CS; Zhu J; Wang H; Huang S; Sze SK; Kon OL
Cell Mol Life Sci; 2011 Jun; 68(11):1983-2002. PubMed ID: 20953656
[TBL] [Abstract][Full Text] [Related]
8. Dual data and motif clustering improves the modeling and interpretation of phosphoproteomic data.
Creixell M; Meyer AS
Cell Rep Methods; 2022 Feb; 2(2):. PubMed ID: 35360705
[TBL] [Abstract][Full Text] [Related]
9. Illuminating the Dark Cancer Phosphoproteome Through a Machine-Learned Co-Regulation Map of 26,280 Phosphosites.
Jiang W; Jaehnig EJ; Liao Y; Yaron-Barir TM; Johnson JL; Cantley LC; Zhang B
bioRxiv; 2024 Mar; ():. PubMed ID: 38562798
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomics reveals CLR interactome in primary human cells.
Manolis D; Hasan S; Maraveyas A; O'Brien DP; Kessler BM; Kramer H; Nikitenko LL
J Biol Chem; 2024 May; ():107399. PubMed ID: 38777147
[TBL] [Abstract][Full Text] [Related]
11. Network-based elucidation of colon cancer drug resistance by phosphoproteomic time-series analysis.
Rosenberger G; Li W; Turunen M; He J; Subramaniam PS; Pampou S; Griffin AT; Karan C; Kerwin P; Murray D; Honig B; Liu Y; Califano A
bioRxiv; 2023 Feb; ():. PubMed ID: 36824919
[TBL] [Abstract][Full Text] [Related]
12. Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis.
Verras GI; Tchabashvili L; Mulita F; Grypari IM; Sourouni S; Panagodimou E; Argentou MI
Breast Cancer (Dove Med Press); 2022; 14():41-61. PubMed ID: 35310681
[TBL] [Abstract][Full Text] [Related]
13. Advances in invasive micropapillary carcinoma of the breast research: A review.
Cheng LH; Yu XJ; Zhang H; Zhang HJ; Jia Z; Wang XH
Medicine (Baltimore); 2024 Jan; 103(1):e36631. PubMed ID: 38181281
[TBL] [Abstract][Full Text] [Related]
14. Integrative proteomic and phosphoproteomic profiling of invasive micropapillary breast carcinoma.
Chen X; Lin Y; Jin X; Zhang W; Guo W; Chen L; Chen M; Li Y; Fu F; Wang C
J Proteomics; 2022 Apr; 257():104511. PubMed ID: 35139397
[TBL] [Abstract][Full Text] [Related]
15. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies.
Ye F; Yu P; Li N; Yang A; Xie X; Tang H; Liu P
Breast; 2020 Jun; 51():11-20. PubMed ID: 32172190
[TBL] [Abstract][Full Text] [Related]
17. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
18. Invasive Micropapillary Carcinoma of the Breast: An Update.
Yang YL; Liu BB; Zhang X; Fu L
Arch Pathol Lab Med; 2016 Aug; 140(8):799-805. PubMed ID: 27472238
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
